Cladis Investment Advisory, LLC Viatris Inc Transaction History

Cladis Investment Advisory, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Oct 09, 2024	SELL	$9.02 - $10.29 $358,490 - $408,965	-39,744 Reduced 62.73%	23,612 $236 Million
Q2 2023 Aug 11, 2023	SELL	$9.02 - $10.29 $178,090 - $203,165	-19,744 Reduced 45.54%	23,612 $235,000
Q1 2023 Oct 09, 2024	BUY	$9.2 - $12.26 $582,875 - $776,744	63,356 New	63,356 $609 Million
Q1 2023 May 15, 2023	SELL	$9.2 - $12.26 $122,663 - $163,462	-13,333 Reduced 23.52%	43,356 $417,000
Q4 2022 Oct 09, 2024	SELL	$8.72 - $11.56 $34,871 - $46,228	-3,999 Reduced 4.96%	76,689 $854 Million
Q4 2022 Feb 14, 2023	SELL	$8.72 - $11.56 $34,871 - $46,228	-3,999 Reduced 6.59%	56,689 $631,000
Q3 2022 Oct 09, 2024	BUY	$8.48 - $11.13 $684,234 - $898,057	80,688 New	80,688 $687 Million
Q3 2022 Nov 17, 2022	SELL	$8.48 - $11.13 $8,480 - $11,130	-1,000 Reduced 1.62%	60,688 $517,000
Q2 2022 Oct 09, 2024	BUY	$9.95 - $12.27 $812,795 - $1 Million	81,688 New	81,688 $855 Million
Q2 2022 Aug 09, 2022	BUY	$9.95 - $12.27 $104,474 - $128,835	10,500 Added 20.51%	61,688 $646,000
Q1 2022 Oct 08, 2024	SELL	$9.81 - $15.4 $3,796 - $5,959	-387 Reduced 0.54%	71,188 $775 Million
Q1 2022 May 10, 2022	SELL	$9.81 - $15.4 $3,796 - $5,959	-387 Reduced 0.75%	51,188 $557,000
Q4 2021 Oct 08, 2024	BUY	$12.09 - $14.68 $865,341 - $1.05 Million	71,575 New	71,575 $968 Million
Q4 2021 Oct 01, 2024	BUY	$12.09 - $14.68 $865,341 - $1.05 Million	71,575 New	71,575 $698 Million
Q4 2021 May 10, 2022	BUY	$12.09 - $14.68 $623,541 - $757,121	51,575 New	51,575 $698,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Cladis Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Cladis Investment Advisory, LLC with notifications on news.